Welcome to the SeraCare Investor Center

 

SeraCare serves the global life sciences industry by providing vital products and services to facilitate the discovery, development and production of human diagnostics and therapeutics.

Our company's innovative portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, biobanking, and contract research services. 

SeraCare's quality systems, scientific expertise and state-of-the-art facilities support its customers in meeting the stringent requirements of the highly-regulated life sciences industry.

Latest News
08/27/08SeraCare Life Sciences to Present at Thomas Weisel Partners Healthcare ConferencePrinter Friendly Version
08/14/08SeraCare Life Sciences Reports Third Quarter Fiscal Year 2008 ResultsPrinter Friendly Version
08/06/08SeraCare Life Sciences to Present at Canaccord Adams 28th Annual Global Growth ConferencePrinter Friendly Version
06/23/08SeraCare Life Sciences' Common Stock Approved for Relisting on NASDAQ Capital Market - Trading to Commence at Market Open TodayPrinter Friendly Version
More >>

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.
SeraCare Stock Price
  
SRLS (Common Stock)
ExchangeNASDAQ CM (US Dollar)
Price$4.13
Change (%)0.00 (0.00%)
Volume0
Data as of 08/27/08 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote

Track Our Progress
  
Webcast ImageWebcast
SeraCare Life Sciences, Inc. at Thomas Weisel Partners Healthcare Conference (Live)
09/04/08 
3:15 p.m. ET

Featured Report 2007 10-k

Receive Email Alerts when certain information is posted Sign up

Upcoming Events View